Table 1.
Clinical characteristics of patients with AML.
| Variables | All patients | Training cohort | Validation cohort |
|---|---|---|---|
| (N = 440) | (n = 309) | (n = 131) | |
| Age | |||
| <14 | 312 (70.9%) | 224 (72.5%) | 88 (67.2%) |
| ≥14 | 128 (29.1%) | 85 (27.5%) | 43 (32.8%) |
| Gender | |||
| Male | 231 (52.5%) | 161 (52.1%) | 70 (53.4%) |
| Female | 209 (47.5%) | 148 (47.9%) | 61 (46.6%) |
| White blood cell | |||
| <100 | 363 (82.5%) | 254 (82.2%) | 109 (83.2%) |
| ≥100 | 77 (17.5%) | 55 (17.8%) | 22 (16.8%) |
| BM leukemic blast percentage | |||
| <90% | 333 (75.7%) | 255 (82.5%) | 78 (59.5%) |
| ≥90% | 107 (24.3%) | 54 (17.5%) | 53 (40.5%) |
| Chromosomal abnormalities | |||
| t(8; 21) | 79 (17.9%) | 58 (18.8%) | 21 (16.1%) |
| Inv(16) | 57 (12.9%) | 39 (12.6%) | 18 (13.7%) |